SGLT2-inhibitors (gliflozins) - multipurpose medications and the statins of the 21st century?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:165 |
|---|---|
| Enthalten in: |
MMW Fortschritte der Medizin - 165(2023), 14 vom: 03. Aug., Seite 46-48 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
SGLT2-Inhibitoren im Alter - auf was Sie achten müssen |
|---|
| Beteiligte Personen: |
Zeeh, Joachim [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 07.08.2023 Date Revised 07.08.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1007/s15006-023-2811-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360371841 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360371841 | ||
| 003 | DE-627 | ||
| 005 | 20231226082856.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s15006-023-2811-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1201.xml |
| 035 | |a (DE-627)NLM360371841 | ||
| 035 | |a (NLM)37537462 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Zeeh, Joachim |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SGLT2-inhibitors (gliflozins) - multipurpose medications and the statins of the 21st century? |
| 246 | 3 | 3 | |a SGLT2-Inhibitoren im Alter - auf was Sie achten müssen |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.08.2023 | ||
| 500 | |a Date Revised 07.08.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Empagliflozin | |
| 650 | 4 | |a SGLT2-inhibitors | |
| 650 | 4 | |a dapagliflozin | |
| 650 | 4 | |a diabetes | |
| 650 | 4 | |a gliflozins | |
| 650 | 4 | |a heart failure | |
| 650 | 7 | |a Benzhydryl Compounds |2 NLM | |
| 650 | 7 | |a Hydroxymethylglutaryl-CoA Reductase Inhibitors |2 NLM | |
| 650 | 7 | |a Hypoglycemic Agents |2 NLM | |
| 650 | 7 | |a Sodium-Glucose Transporter 2 Inhibitors |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t MMW Fortschritte der Medizin |d 1999 |g 165(2023), 14 vom: 03. Aug., Seite 46-48 |w (DE-627)NLM103996869 |x 1613-3560 |7 nnns |
| 773 | 1 | 8 | |g volume:165 |g year:2023 |g number:14 |g day:03 |g month:08 |g pages:46-48 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s15006-023-2811-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 165 |j 2023 |e 14 |b 03 |c 08 |h 46-48 | ||